AT331406B - Verfahren zur herstellung neuer antibiotisch wirksamer verbindungen - Google Patents
Verfahren zur herstellung neuer antibiotisch wirksamer verbindungenInfo
- Publication number
- AT331406B AT331406B AT778874A AT778874A AT331406B AT 331406 B AT331406 B AT 331406B AT 778874 A AT778874 A AT 778874A AT 778874 A AT778874 A AT 778874A AT 331406 B AT331406 B AT 331406B
- Authority
- AT
- Austria
- Prior art keywords
- active compounds
- producing new
- antibiotically active
- new antibiotically
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D269/00—Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups C07D261/00 - C07D267/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT723575A AT335064B (de) | 1973-09-28 | 1975-09-22 | Verfahren zur herstellung neuer antibiotisch wirksamer verbindungen |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1396673A CH594677A5 (en) | 1973-09-28 | 1973-09-28 | 3-(4-Substd.-1-piperazinyl) rifamycin S and SV derivs |
CH1396473A CH594676A5 (en) | 1973-09-28 | 1973-09-28 | 3-(4-Substd.-1-piperazinyl) rifamycin S and SV derivs |
CH1031474A CH622797A5 (en) | 1974-07-26 | 1974-07-26 | Process for the preparation of antibiotically active rifamycin S and SV derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA778874A ATA778874A (de) | 1975-11-15 |
AT331406B true AT331406B (de) | 1976-08-25 |
Family
ID=27176412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT778874A AT331406B (de) | 1973-09-28 | 1974-09-27 | Verfahren zur herstellung neuer antibiotisch wirksamer verbindungen |
Country Status (24)
Country | Link |
---|---|
JP (1) | JPS6012358B2 (ja) |
AR (2) | AR211845A1 (ja) |
AT (1) | AT331406B (ja) |
BG (2) | BG25231A3 (ja) |
CA (1) | CA1055934A (ja) |
CS (1) | CS199258B2 (ja) |
DD (1) | DD114951A5 (ja) |
DE (1) | DE2444728A1 (ja) |
DK (1) | DK145949C (ja) |
EG (1) | EG11775A (ja) |
ES (1) | ES430524A1 (ja) |
FI (1) | FI241674A (ja) |
FR (1) | FR2245359B1 (ja) |
GB (1) | GB1483621A (ja) |
HU (1) | HU175580B (ja) |
IE (1) | IE39919B1 (ja) |
IL (1) | IL45735A (ja) |
NL (1) | NL7412729A (ja) |
NO (1) | NO743174L (ja) |
OA (1) | OA04783A (ja) |
RO (1) | RO71721A (ja) |
SE (1) | SE420494B (ja) |
SU (2) | SU644388A3 (ja) |
YU (2) | YU39929B (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1486118A (en) * | 1975-03-05 | 1977-09-21 | Lepetit Spa | Rifamycin derivatives |
NZ553202A (en) | 2004-08-19 | 2010-12-24 | Vertex Pharma | Modulators of muscarinic receptors |
AU2006330866A1 (en) | 2005-12-22 | 2007-07-05 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
US7858790B2 (en) | 2006-06-29 | 2010-12-28 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
-
1974
- 1974-08-08 DK DK422874A patent/DK145949C/da not_active IP Right Cessation
- 1974-08-15 FI FI2416/74A patent/FI241674A/fi unknown
- 1974-08-16 SE SE7410465A patent/SE420494B/xx unknown
- 1974-09-04 NO NO743174A patent/NO743174L/no unknown
- 1974-09-13 GB GB40048/74A patent/GB1483621A/en not_active Expired
- 1974-09-18 FR FR7431472A patent/FR2245359B1/fr not_active Expired
- 1974-09-19 DE DE19742444728 patent/DE2444728A1/de not_active Withdrawn
- 1974-09-23 OA OA55303A patent/OA04783A/xx unknown
- 1974-09-25 IL IL45735A patent/IL45735A/xx unknown
- 1974-09-25 YU YU2611/74A patent/YU39929B/xx unknown
- 1974-09-26 CA CA210,125A patent/CA1055934A/en not_active Expired
- 1974-09-26 AR AR255770A patent/AR211845A1/es active
- 1974-09-26 SU SU742062680A patent/SU644388A3/ru active
- 1974-09-26 DD DD181346A patent/DD114951A5/xx unknown
- 1974-09-26 NL NL7412729A patent/NL7412729A/xx not_active Application Discontinuation
- 1974-09-26 RO RO7491068A patent/RO71721A/ro unknown
- 1974-09-27 HU HU74CI1512A patent/HU175580B/hu unknown
- 1974-09-27 IE IE2012/74A patent/IE39919B1/xx unknown
- 1974-09-27 CS CS746665A patent/CS199258B2/cs unknown
- 1974-09-27 BG BG030425A patent/BG25231A3/xx unknown
- 1974-09-27 AT AT778874A patent/AT331406B/de not_active IP Right Cessation
- 1974-09-27 BG BG027789A patent/BG25378A3/xx unknown
- 1974-09-28 JP JP49111016A patent/JPS6012358B2/ja not_active Expired
- 1974-09-28 ES ES430524A patent/ES430524A1/es not_active Expired
- 1974-09-28 EG EG433/74A patent/EG11775A/xx active
-
1975
- 1975-05-28 AR AR258992A patent/AR223798A1/es active
- 1975-07-31 SU SU752162195A patent/SU652895A3/ru active
-
1980
- 1980-12-10 YU YU3129/80A patent/YU40242B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT338261B (de) | Verfahren zur herstellung neuer pyridinverbindungen | |
AT334362B (de) | Verfahren zur herstellung neuer heterocyclischer verbindungen und ihrer salze | |
AT336631B (de) | Verfahren zur herstellung neuer diphenylharnstoffe | |
AT340042B (de) | Verfahren zur herstellung von neuen antibiotischen verbindungen | |
CH551965A (de) | Verfahren zur herstellung antibiotisch wirksamer verbindungen. | |
AT322098B (de) | Verfahren zur herstellung neuer antibiotischer verbindungen | |
ATA504374A (de) | Verfahren zur herstellung neuer haptensteroide | |
AT332389B (de) | Verfahren zur herstellung neuer heterocyclischer verbindungen | |
ATA208576A (de) | Verfahren zur herstellung neuer alfa-athylbenzhydrol-derivate | |
AT347971B (de) | Verfahren zur herstellung neuer phosphor- organischer verbindungen | |
AT337165B (de) | Verfahren zur herstellung neuer phenylpropenylaminderivate | |
AT331406B (de) | Verfahren zur herstellung neuer antibiotisch wirksamer verbindungen | |
AT334365B (de) | Verfahren zur herstellung neuer thiazol-5-methanol-derivate | |
AT328084B (de) | Verfahren zur herstellung neuer antibiotika | |
AT338245B (de) | Verfahren zur herstellung neuer aryloxyalkyldiketonen | |
AT335064B (de) | Verfahren zur herstellung neuer antibiotisch wirksamer verbindungen | |
ATA818373A (de) | Verfahren zur herstellung neuer heterocyclischer verbindungen | |
AT347032B (de) | Verfahren zur herstellung neuer antibiotika | |
AT331224B (de) | Verfahren zur herstellung neuer alfa-carboxy-benzylsulfonsaureester | |
AT325039B (de) | Verfahren zur herstellung neuer kanthoncarbon säureverbindungen | |
AT322542B (de) | Verfahren zur herstellung neuer nitrofuranverbindungen | |
AT346485B (de) | Verfahren zur herstellung neuer cephalosporin- verbindungen | |
AT336200B (de) | Verfahren zur herstellung neuer cardenolidacetale | |
ATA986376A (de) | Verfahren zur herstellung neuer haptensteroide | |
AT351029B (de) | Verfahren zur herstellung neuer hetero- cyclischer verbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |